Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Adobe
ADBE
|
$593M |
| 2 |
Tesla
TSLA
|
$473M |
| 3 |
NVIDIA
NVDA
|
$470M |
| 4 |
Nike
NKE
|
$403M |
| 5 |
AstraZeneca
AZN
|
$401M |
Top Sells
| 1 |
Amazon
AMZN
|
$897M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$578M |
| 3 |
Moderna
MRNA
|
$457M |
| 4 |
Aon
AON
|
$410M |
| 5 |
Apple
AAPL
|
$401M |
Sector Composition
| 1 | Technology | 20.43% |
| 2 | Healthcare | 20.23% |
| 3 | Consumer Staples | 11.18% |
| 4 | Consumer Discretionary | 9.83% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Biogen
BIIB
$20.5B
| $278M | 0.36% |
981,707
-348,296
| -26% | -$98.6M |
|
52
Novartis
NVS
$245B
| $270M | 0.35% |
3,307,237
+897,298
| +37% | +$73.4M |
|
53
Caterpillar
CAT
$196B
| $265M | 0.34% |
1,382,300
+339,522
| +33% | +$65.2M |
|
54
DocuSign
DOCU
$15B
| $263M | 0.34% |
1,020,500
+1,005,400
| +6,658% | +$259M |
|
55
Jazz Pharmaceuticals
JAZZ
$7.75B
| $260M | 0.34% |
1,999,009
-318,231
| -14% | -$41.4M |
|
56
PepsiCo
PEP
$206B
| $258M | 0.33% |
1,716,862
+977,600
| +132% | +$147M |
|
57
Colgate-Palmolive
CL
$67.9B
| $258M | 0.33% |
3,408,081
+1,529,100
| +81% | +$116M |
|
58
Chevron
CVX
$326B
| $256M | 0.33% |
2,523,725
+1,918,630
| +317% | +$195M |
|
59
General Mills
GIS
$26.4B
| $255M | 0.33% |
4,270,888
+556,600
| +15% | +$33.3M |
|
60
GE Aerospace
GE
$292B
| $249M | 0.32% |
2,419,757
+226,883
| +10% | +$23.4M |
|
61
Eli Lilly
LLY
$659B
| $243M | 0.31% |
1,053,447
+967,347
| +1,124% | +$224M |
|
62
Procter & Gamble
PG
$370B
| $237M | 0.31% |
1,698,523
+1,103,271
| +185% | +$154M |
|
63
Cable One
CABO
$909M
| $232M | 0.3% |
128,200
-36,800
| -22% | -$66.7M |
|
64
Visa
V
$679B
| $229M | 0.3% |
1,027,700
+622,300
| +154% | +$139M |
|
65
National Beverage
FIZZ
$3.94B
| $226M | 0.29% |
4,314,544
-70,400
| -2% | -$3.7M |
|
66
AbbVie
ABBV
$374B
| $223M | 0.29% |
2,070,894
+1,340,970
| +184% | +$145M |
|
67
Booking.com
BKNG
$181B
| $216M | 0.28% |
91,199
+86,800
| +1,973% | +$206M |
|
68
Uber
UBER
$194B
| $216M | 0.28% |
4,820,200
+4,741,300
| +6,009% | +$212M |
|
69
Clorox
CLX
$14.7B
| $214M | 0.28% |
1,293,130
+225,100
| +21% | +$37.3M |
|
70
McDonald's
MCD
$225B
| $212M | 0.27% |
878,906
+337,406
| +62% | +$81.4M |
|
|
MBT
71
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $204M | 0.26% |
21,205,357
-903,217
| -4% | -$8.71M |
|
|
B
72
Barrick Mining Corporation
B
$45.9B
| $197M | 0.25% |
10,910,876
-1,079,500
| -9% | -$19.5M |
|
73
TSMC
TSM
$1.18T
| $196M | 0.25% |
1,757,020
+439,700
| +33% | +$49.1M |
|
74
Union Pacific
UNP
$133B
| $194M | 0.25% |
988,900
+303,600
| +44% | +$59.5M |
|
75
American Electric Power
AEP
$58.9B
| $190M | 0.25% |
2,337,400
+1,249,100
| +115% | +$101M |
|